We examine four internet diabetes “breakthrough” treatments, from superfruits to luxury spas.
Dr. Douglas Melton describes how his Harvard team required years of research to achieve 2014’s beta cell breakthrough.
Thanks to islet transplant therapy, Jill Eastman hasn’t thought much about her Type 1 diabetes in the last 10 years.
Nuvilex plans to create a diabetes treatment with liver-grown beta cells.
Human trials show the vaccine might repair the pancreas in those who have long had Type 1.
The Diabetes Research Institute shares its top breakthroughs of the past year.
People with Type 1 can electronically sign up for the T1D Exchange Living BioBank to be considered for future studies.
Which diabetes organization spends your contributions most wisely?
The Insulin Nation Research Roundup for October 2014
A endocrinologist evaluates the potential for Dr. Douglas Melton’s new technique to grow insulin-producing beta cells.
A T1D activist and researcher dives into the available research for clues.
With new diagnostic tools, doctors can track the insulin production of people with diabetes who are long past the honeymoon period.
By volunteering to undergo an experimental islet therapy transplant, Chris Stiehl possibly shaved years off the research timeline.
Type 1 diabetes research has had a lot of dead ends over the years, but Dr. Levetan hopes each research effort can lead to greater T1D understanding.
Could regenerative therapy, combined with immunotherapy, be the next leap forward?
The Juvenile Diabetes Cure Alliance wants a practical cure now, and they aren’t afraid to ruffle some feathers to get it.
Researchers are trying to discover why Finland has 6 times the rate of Type 1 diabetes of Russia.
A new initiative called One Florida gets diabetes researchers across the state to work together for a cure.
A noted endocrinologist says we know enough to make people with T1 insulin independent again.
Could a T1 rebranding bring scientists closer to a cure?